RAYMOND JAMES & ASSOCIATES - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 13 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$23,000
-42.5%
11,570
+0.6%
0.00%
Q2 2021$40,000
+471.4%
11,500
-4.2%
0.00%
Q1 2020$7,000
-41.7%
12,0000.0%0.00%
Q4 2019$12,000
+33.3%
12,0000.0%0.00%
Q3 2019$9,000
-25.0%
12,0000.0%0.00%
Q2 2019$12,000
-29.4%
12,0000.0%0.00%
Q1 2019$17,000
+41.7%
12,0000.0%0.00%
Q4 2018$12,000
-42.9%
12,0000.0%0.00%
Q3 2018$21,000
-25.0%
12,0000.0%0.00%
Q2 2018$28,000
-24.3%
12,0000.0%0.00%
Q1 2018$37,000
-19.6%
12,0000.0%0.00%
Q4 2017$46,00012,0000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Key Bridge Compliance, LLC 154,130$105,4870.03%
CHELSEA COUNSEL CO 81,300$55,6420.03%
Inspire Advisors, LLC 186,410$127,5790.02%
Horst & Graben Wealth Management LLC 75,722$51,8240.01%
GSA CAPITAL PARTNERS LLP 198,492$1360.01%
Arkadios Wealth Advisors 100,000$68,4400.01%
Miller Investment Management, LP 50,000$34,2200.01%
XTX Topco Ltd 29,077$19,9000.00%
Measured Wealth Private Client Group, LLC 10,000$6,8440.00%
Pasadena Private Wealth, LLC 10,965$7,5040.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders